Mrsa Complicating a Parapneumonic Effusion Despite Timely Antibiotics

Rutenberg, David; Zhang, Y.

doi:10.1016/j.chest.2020.05.119

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Therefore, the best solution would be to recognize this infection as early as possible by considering MRSA infections in a clinical picture of pneumonia and timely antimicrobial therapy with appropriate antibiotics to improve the clinical prognosis of the disease. 17…”

Section: Discussionmentioning

confidence: 99%

Community-acquired Methicillin-resistant Staphylococcus aureus Pneumonia and Parapneumonic Effusion in a Male Patient with Diabetes: A Case Report

Sathyakamala¹,

Shanmugam²,

Meenakshi³

2022

J. Pure Appl. Microbiol.

View full text Add to dashboard Cite

Methicillin-resistant Staphylococcus aureus (MRSA) infections are a primary health concern. They are commonly differentiated as hospital-acquired methicillin-resistant Staphylococcus aureus (HA-MRSA) and community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) infections, based on their epidemiology, susceptibility findings, and molecular typing patterns. Therefore, appropriate contact precautions and isolation measures should be implemented. CA-MRSA mostly causes skin and soft-tissue infections, but the probability and incidence of it causing sepsis and invasive infections have increased dramatically in recent years. In this study, we report a case of CA-MRSA pneumonia with pan-pneumonic effusion in a 59-year-old male diabetic patient with preexisting comorbidities such as diabetic ketoacidosis and non-ST elevated myocardial infarction. The early reporting of the organism’s identity and its antimicrobial susceptibility, as well as timely initiation of antibiotic therapy, aided in the successful management and cure of the patient.

show abstract

Section: Discussionmentioning

confidence: 99%